NICE Recommends Several Treatment Options To Help Thousands Of People With Moderate Rheumatoid Arthritis | News and Features | New

NICE counts today (10e June) published the final version of the guide which recommends several treatment options for about 25,000 people with moderate rheumatoid arthritis who have not responded to conventional therapies. Adalimumab, etanercept, and infliximab, taken with methotrexate, have been recommended for use in the NHS. Adalimumab and etanercept …

Read More »